Supreme Pharmaceuticals Inc

FIRE-X

CVE:FIRE

2.26
0.12 (5.61%)
The Supreme Cannabis Co Inc is engaged in production and sale of medical cannabis. The company is a cultivator and distributor of sun-grown cannabis through its wholly-owned subsidiary 7ACRES.
More at Wikipedia

Analysis and Opinions about FIRE-X

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
August 16, 2019
Go all in into this? Don't go all in into any cannabis stock, a sector that hasn't shown earnings yet. He has a convertible debenture of Supreme, who have executed well. But this space is now under tremendous pressure, ever since legalization.
Go all in into this? Don't go all in into any cannabis stock, a sector that hasn't shown earnings yet. He has a convertible debenture of Supreme, who have executed well. But this space is now under tremendous pressure, ever since legalization.
James Hodgins
Chief Investment Officer, Curvature Hedge Strategies
Price
$0.000
Owned
Yes
BUY
BUY
July 22, 2019
One of the better cannabis growers, producing high-quality flower which pays wider margins. Well-run. Stick with this, though this space has pulled back lately after scaling nosebleed high valuations just a few months ago.
One of the better cannabis growers, producing high-quality flower which pays wider margins. Well-run. Stick with this, though this space has pulled back lately after scaling nosebleed high valuations just a few months ago.
Gerard Ferguson
CEO & Portfolio Manager, Jemekk Capital Management
Price
$0.000
Owned
No
WATCH
WATCH
October 17, 2018

He has looked closely at this and now sees them stepping out to provide high quality bud to other producers. They just signed a major contract to supply Tilray (TLRY-N), which he feels adds substantial credibility to their business model. The risk lies in them not having a distinct brand.

He has looked closely at this and now sees them stepping out to provide high quality bud to other producers. They just signed a major contract to supply Tilray (TLRY-N), which he feels adds substantial credibility to their business model. The risk lies in them not having a distinct brand.

Charles Taersk
President and CEO, Faircourt Asset Management
Price
$2.020
Owned
No
DON'T BUY
DON'T BUY
August 28, 2018

Everything moved up on Monday, it felt like a compulsory buy. He used to own it but owns only debentures and warrants now. It’s a plain vanilla cannabis company--growers. They don’t plan to retail, they plan to sell to retailers. They seem to know what they’re doing, but in terms of new investments, there are others that he likes better.

Everything moved up on Monday, it felt like a compulsory buy. He used to own it but owns only debentures and warrants now. It’s a plain vanilla cannabis company--growers. They don’t plan to retail, they plan to sell to retailers. They seem to know what they’re doing, but in terms of new investments, there are others that he likes better.

James Hodgins
Chief Investment Officer, Curvature Hedge Strategies
Price
$1.840
Owned
No
COMMENT
COMMENT
March 26, 2018

He owns a convertible debenture and some warrants, but is short some of the stock as a hedge against it. He does not have a particular view in the near term. He sees them as capable operators. He would put them in the upper quartile area of the sector, but believes the cultivators are generally over-valued.

He owns a convertible debenture and some warrants, but is short some of the stock as a hedge against it. He does not have a particular view in the near term. He sees them as capable operators. He would put them in the upper quartile area of the sector, but believes the cultivators are generally over-valued.

James Hodgins
Chief Investment Officer, Curvature Hedge Strategies
Price
$1.780
Owned
Yes
BUY
BUY
August 31, 2017

It is going to have a premium recreational weed product. It really wants to grow good ‘stuff’. When the market comes out there are going to be premium products. They are expanding in a disciplined way and increasing the grow rooms. They are going to have 340,000 sq. ft. by 2019.

It is going to have a premium recreational weed product. It really wants to grow good ‘stuff’. When the market comes out there are going to be premium products. They are expanding in a disciplined way and increasing the grow rooms. They are going to have 340,000 sq. ft. by 2019.

Chris Damas
Editor, The BCMI Report
Price
$1.210
Owned
Unknown
BUY
BUY
July 6, 2017

Just got its sales license. They have a dried bud business model. Management are smart and are holding back on spending their capital. It is interesting and he likes that they are not making wild expansion plans.

Just got its sales license. They have a dried bud business model. Management are smart and are holding back on spending their capital. It is interesting and he likes that they are not making wild expansion plans.

Chris Damas
Editor, The BCMI Report
Price
$1.120
Owned
Unknown
BUY
BUY
June 23, 2017

Cannabis. They’ve had their cultivation license for a long time. There should be no problem. Seem to have a well-run operation. Management is fine. Once they get the sales license, there is some good upside in the stock. This is a reasonable time to be picking away at stocks like this.

Cannabis. They’ve had their cultivation license for a long time. There should be no problem. Seem to have a well-run operation. Management is fine. Once they get the sales license, there is some good upside in the stock. This is a reasonable time to be picking away at stocks like this.

James Hodgins
Chief Investment Officer, Curvature Hedge Strategies
Price
$1.290
Owned
Yes
COMMENT
COMMENT
April 26, 2017

A lot of people have been concerned about the sales license with this company. They were very close to getting their sales license from Health Canada, and then there were pesticide issues with some other companies. Health Canada asked the company to look at some of the fertilizers they were using. Now they have to get those onto an approved list before getting their sales license. It’s just a longer review process than what was expected.

A lot of people have been concerned about the sales license with this company. They were very close to getting their sales license from Health Canada, and then there were pesticide issues with some other companies. Health Canada asked the company to look at some of the fertilizers they were using. Now they have to get those onto an approved list before getting their sales license. It’s just a longer review process than what was expected.

Bruce Campbell (2)
President & Portfolio Manager, Stone Castle Investment Management Inc.
Price
$1.480
Owned
Unknown
Showing 1 to 9 of 9 entries
  • «
  • 1
  • »